| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-05 |